GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 85 filers reported holding GLYCOMIMETICS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $765,000 | -17.4% | 64,210 | -13.6% | 0.00% | 0.0% |
| Q1 2019 | $926,000 | +28.4% | 74,310 | -2.4% | 0.00% | 0.0% |
| Q4 2018 | $721,000 | -31.1% | 76,110 | +4.7% | 0.00% | -50.0% |
| Q3 2018 | $1,046,000 | -6.3% | 72,672 | +5.1% | 0.00% | 0.0% |
| Q2 2018 | $1,116,000 | +21.7% | 69,172 | +22.5% | 0.00% | +100.0% |
| Q1 2018 | $917,000 | +118.3% | 56,472 | +125.9% | 0.00% | 0.0% |
| Q4 2017 | $420,000 | +18.6% | 25,000 | -1.2% | 0.00% | 0.0% |
| Q3 2017 | $354,000 | -2.2% | 25,300 | -21.9% | 0.00% | 0.0% |
| Q2 2017 | $362,000 | – | 32,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,229,856 | $45,186,000 | 5.74% |
| NEA Management Company, LLC | 8,584,128 | $120,092,000 | 4.21% |
| NEXTHERA CAPITAL LP | 321,286 | $4,495,000 | 1.16% |
| Redmile Group, LLC | 1,214,088 | $16,985,000 | 0.84% |
| EAM Investors, LLC | 371,030 | $5,191,000 | 0.69% |
| Schonfeld Strategic Advisors LLC | 500,104 | $6,996,000 | 0.64% |
| ELEMENT CAPITAL MANAGEMENT LLC | 29,909 | $418,000 | 0.17% |
| Jafra Capital Management LP | 16,839 | $236,000 | 0.09% |
| PRENTISS SMITH & CO INC | 20,000 | $280,000 | 0.08% |
| Endurant Capital Management LP | 17,607 | $246,000 | 0.08% |